Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease

Yoon, Hyuk; Yang, Suk Kyun; So, Hoonsub; Lee, Ko Eun; Park, Sang Hyoung; Jung, Sung Ae; Choh, Joong Haeng; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Hoon

doi:10.3904/kjim.2017.104

Cited by 19 publications

(26 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, as the CCKNOW was inappropriate to investigate the relationship between disease-related knowledge and medical acceleration, we employed the IBD-KNOW questionnaire, which is an updated measurement tool regarding several items including biologics and vaccination. [12] We thus also hope that further studies will now be conducted using the IBD-KNOW.…”

Section: Plos Onementioning

confidence: 99%

“…However, knowledge levels regarding IBD were shown to be independent of the disease duration in a previous study and our analysis. [11,12] Another limitation was that we employed a relatively short follow-up duration and could not evaluate the long-term outcomes associated with medical acceleration. Further studies with longer follow-up durations and more events will be needed.…”

Section: Plos Onementioning

confidence: 99%

“…Therefore, a novel disease-related knowledge score, the Inflammatory Bowel Disease Knowledge (IBD-KNOW) score, was developed and validated. [12] Recently, the usefulness of the IBD-KNOW questionnaire was identified in both the United States and Korean patients. [13] Several studies have investigated the independent risk factors of a poor IBD-KNOW score.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background and aims The disease-related knowledge levels in patients with inflammatory bowel disease (IBD) are important because it could affect the self-management ability and adaptive coping strategies. We set out to determine whether higher levels of disease-related knowledge reduce medical acceleration. Methods We evaluated the levels of disease-related knowledge in all patients at the time of enrollment for SNUBH IBD cohort using the validated IBD-KNOW questionnaire. Clinical data were prospectively collected and the factors related to step-up therapy were analyzed. Step-up therapy was defined as the new use of corticosteroids, immunomodulators, or biologics after the enrollment. Results Between April 2017 and January 2019, 298 patients were enrolled (mean age, 39.8 years; males, 69.5%); 193 patients (64.8%) had ulcerative colitis and 105 (35.2%) had Crohn's disease. The mean disease duration was 35.8 months. During the mean follow-up of 14.7 months, 90 patients (30.2%) underwent step-up therapy and 208 (69.8%) underwent continuous therapy. The prevalence of continuous therapy increased with increasing IBD-KNOW scores (p for trend = 0.019). Cox proportional hazards analysis revealed that high IBD-KNOW scores (� 16) (hazards ratio [HR]: 0.498, 95% confidence interval [CI]: 0.276-0.897, p = 0.020) was negatively associated with the step-up therapy. Conclusions Higher disease-related knowledge could reduce the requirement of step-up therapy in IBD. The IBD-KNOW score was independently predictive of step-up therapy.

show abstract

Section: Plos Onementioning

confidence: 99%

Section: Plos Onementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…Five studies were identified that measured general IBD knowledge in adults (Table 1); the Knowledge Questionnaire (KQ) [44], the Crohn's and Colitis Knowledge Score (CC-KNOW) [25], Inflammatory Bowel Disease Knowledge (IBD-KNOW) [45], the IBD-knowledge questionnaire Catalonia (QUECOMIICAT) [46] and a short questionnaire by Keegan et al [47]. These assessment tools may be appropriate for adolescents but have not been validated in younger children and contain complex items, alongside topics such as pregnancy and smoking that may be inappropriate to ask young children.…”

Section: Knowledge Outcome Measuresmentioning

confidence: 99%

Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease

2021

View full text Add to dashboard Cite

Self-management is a multi-modal approach for managing chronic conditions that encompasses a number of different elements; knowledge, adherence, self-regulation, communication, and cognitive factors. Self-management has been shown to be beneficial for adults with inflammatory bowel disease (IBD), and for children with IBD it may help them learn to take control of their complex treatment regimens and lead to positive disease outcomes. The development of self-management skills for children with IBD is vital in order to maximize their potential for health autonomy, but it is still an emergent field in this population. This review provides an over-arching view of the self-management elements specific to children with IBD, and highlights outcome measures that may be used to assess skills within each field as well as the efficacy of targeted interventions.

show abstract

“…43 Additional support can increase patients' IBD knowledge, help address feelings of isolation, identify strategies to cope with setbacks, and improve treatment adherence. 23,46 APPs have a role in advocating for patients and facilitating patient-physician communication. 1 Despite 98% of IBD patients considering it important that they be involved in the decisionmaking process, 21 patients report frustration at the lack of collaborative long-term goal setting with physicians treating their IBD.…”

Section: Psychological Supportmentioning

confidence: 99%

Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers

Drescher¹,

Lissoos²,

Hajisafari³

et al. 2019

The Journal for Nurse Practitioners

View full text Add to dashboard Cite

Updated therapeutic guidelines for inflammatory bowel disease call for effective disease assessment, early intervention, and personalized patient care using a treat-to-target (T2T) approach. The ongoing, intensive monitoring of a T2T strategy is best facilitated by a multidisciplinary team, but the increased demand on health care systems impedes implementation. Therefore, advanced practice providers have a growing role in bridging the gap between T2T recommendations and clinical practice. Advanced practice providers can effectively facilitate patient-care team communication, deliver patient education, perform in-clinic and remote monitoring of symptoms and treatment response, and assist patients with self-management.

show abstract

Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease

Abstract: The IBD-KNOW demonstrated excellent test characteristics. Hospitalization history, education level, and information acquired from patient organization play an important role in correct IBD-related knowledge.

Cited by 19 publications

References 27 publications

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease

Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease

Treat-to-Target Approach in Inflammatory Bowel Disease: The Role of Advanced Practice Providers

Contact Info

Product

Resources

About